|
Accueil > Actualité
AstraZeneca: invests $2.5bn in R&D centre in Beijing
(CercleFinance.com) - AstraZeneca has announced a $2.
5bn investment in Beijing to establish its sixth global strategic R&D centre, the second in China, after Shanghai. This project is part of a strategic partnership with the Beijing Municipal Government and the Beijing Economic and Technological Development Zone Administration. The five-year investment includes research agreements with biotechs Harbour BioMed, Syneron Bio and BioKangtai. The R&D centre will be located in Beijing's BioPark, close to biotechs and research hospitals. AstraZeneca also plans to create 1,700 jobs in Beijing. Copyright (c) 2025 CercleFinance.com. All rights reserved. |
28/03/2025 17:20
BMWmise en service d'un nouvel atelier à Ratisbonne 28/03/2025 16:56 Intelle second volet de l'opération SK hynix est bouclé 28/03/2025 16:34 Equinorsigne un contrat de 330 M$ avec Island Drilling 28/03/2025 16:24 Memscaple titre surnage grâce à son carnet de commandes 28/03/2025 16:10 Hexaomchute de 58% du résultat net annuel 28/03/2025 15:55 Nanobiotixdes données favorables dans le CPNPC Tous les articles sociétés |
